Buctolan, Baby Boy .

HRN: 24-45-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
01/26/2024
02/01/2024
IV
24mg As LD Then 12mg
Q24
Prematurity
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: